Highlights BioPharma Credit PLC

Equities

BPCP

GB00BDGKMY29

Delayed London S.E. Other stock markets 06:32:08 2024-06-07 am EDT			5-day change	1st Jan Change
0.8425 ^USD	+0.30%		+0.78%	+0.30%

May. 02	BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg	MT
May. 02	BioPharma Credit agrees USD400 million loan for oncology firm Novacure	AN

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BioPharma Credit Enters $400 Million Loan Agreement with Novocure Luxembourg	May. 02	MT
BioPharma Credit agrees USD400 million loan for oncology firm Novacure	May. 02	AN
BioPharma Credit to loan USD100 million to Tarsus Pharmaceuticals	Apr. 24	AN
BioPharma Credit PLC Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
BioPharma Credit net asset value ticks up but total payout lower	Mar. 27	AN
Tranche Update on BioPharma Credit PLC's Equity Buyback Plan announced on May 31, 2023.	Mar. 27	CI
Biopharma Credit plc Declares Interim Dividend in Respect of the Financial Period Ending 31 March 2024, Payable on 30 April 2024	Mar. 21	CI
BioPharma Credit gets USD50.6 million from Abbvie's ImmunoGen purchase	Feb. 13	AN
Biopharma Credit Secures $51 Million Loan Repayment from US Biotech ImmunoGen	Feb. 13	MT
BioPharma Credit PLC Declares Interim Special Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024	Feb. 08	CI
BioPharma Credit PLC Declares Ordinary Interim Dividend in Respect of the Financial Period Ending 31 December 2023, Payable on 15 March 2024	Feb. 08	CI
Barratt takes over Redrow in GBP2.5 billion deal	Feb. 07	AN
BioPharma Credit to receive partial prepayment of loan	Feb. 06	AN
BioPharma Credit to fund LumiraDx ahead of acquisition by Roche	Jan. 02	AN
BioPharma Credit notes AbbVie takeover of investee ImmunoGen	Dec. 01	AN
Biopharma Credit plc Declares Special Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024	Nov. 29	CI
BioPharma Credit PLC Declares Interim Dividend in Respect of the Financial Period Ended 30 September 2023, Payable on 5 January 2024	Nov. 29	CI
BioPharma Credit PLC Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-28	CI
BioPharma Credit hails "attractive pipeline" and backs dividend target	23-09-27	AN
BioPharma Credit PLC Provides Dividend Guidance for the Full Year Ending December 31, 2023	23-09-27	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioPharma Credit PLC

Equities

BPCP

GB00BDGKMY29

Highlights

Filters